Home Cart Sign in  
Chemical Structure| 498-02-2 Chemical Structure| 498-02-2

Structure of Apocynin
CAS No.: 498-02-2

Chemical Structure| 498-02-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Apocynin is a selective NADPH-oxidase inhibitor with an IC50 of 10 μM. It improves acute lung inflammation in a Carrageenan-induced pleurisy mice model, can be used for cancer research, and reverses aging in mesenchymal stem cells to promote osteogenesis and increase bone mass.

Synonyms: Acetovanillone; Acetoguaiacone; NSC 209524

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Apocynin

CAS No. :498-02-2
Formula : C9H10O3
M.W : 166.17
SMILES Code : O=C(C1=CC=C(O)C(OC)=C1)C
Synonyms :
Acetovanillone; Acetoguaiacone; NSC 209524
MDL No. :MFCD00008747
InChI Key :DFYRUELUNQRZTB-UHFFFAOYSA-N
Pubchem ID :2214

Safety of Apocynin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03376555 Microvascular Dysfunction Phase 1 Phase 2 Recruiting June 30, 2019 United States, Pennsylvania ... More >> Pennsylvania State University Recruiting University Park, Pennsylvania, United States, 16802 Less <<
NCT03680573 Cardiovascular Diseases ... More >> Cardiovascular Risk Factor Vasoconstriction Less << Phase 1 Completed - United States, Texas ... More >> Engineering Research Building Arlington, Texas, United States, 76019 Less <<
NCT03680638 Cardiovascular Diseases ... More >> Cardiovascular Risk Factor Vasodilation Less << Phase 1 Completed - United States, Texas ... More >> Engineering Research Building Arlington, Texas, United States, 76019 Less <<
NCT01402297 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 1 Completed - -
NCT00992667 Bronchial Asthma Phase 1 Completed - Poland ... More >> Medical University of Lodz Lodz, Lodzkie, Poland, 92-213 Less <<
NCT03680404 Cardiovascular Diseases ... More >> Cardiovascular Risk Factor Vasoconstriction Less << Phase 1 Not yet recruiting October 1, 2019 United States, Texas ... More >> Engineering Research Building Not yet recruiting Arlington, Texas, United States, 76019 Contact: R. Matthew Brothers, PhD    8172723156    matthew.brothers@uta.edu    Contact: John D Akins, MS    8172721835    john.akins@uta.edu Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

6.02mL

1.20mL

0.60mL

30.09mL

6.02mL

3.01mL

60.18mL

12.04mL

6.02mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories